Please assess the completion status of the following clinical trial:

Trial Title: A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All children between the ages of 2-5 years who meet diagnostic criteria for Autism or Pervasive Developmental Disorder by DSM IV criteria who are referred for treatment at Mifne for the treatment group.~* The control group will consist of children meeting the same criteria who are referred to Schneider Children's Medical Center of Israel (SCMCI). Matching will be for age, sex, ethnicity, socioeconomic status, IQ, language development and diagnosis.~Exclusion criteria:~* All referred children who do not meet criteria for Autism or PDD or do not understand Hebrew.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: OTHER): Mifne Approach to PDD
- B (Type: OTHER): Treatment as usual

Based on this trial design, predict the completion outcome and termination type (if applicable).